Using immunotherapy can reduce risk of returning skin cancer - Study

A new study shows using an immunotherapy can significantly reduce the risk of a patient's skin cancer returning.

Nearly two thirds of of patients treated with nivolumab at an earlier stage alongside surgery, experienced recurrence-free survival.

Anne Gribben from Dublin was diagnosed with stage three malignant melanoma in 2006 and is still cancer-free as a result of the treatment.

She was given one of two drug treatment options and says her health has been great since.

She said: "The results have been good because everything has been clear since and I started that in 2015."

File image.

- Digital Desk

More in this Section

Man due in court charged in connection with Dublin drugs raid

Tougher than ever to make false claim says Motor Insurers' Bureau of Ireland

More than 50,000 students receive CAO round one offers

Post-mortems due on bodies of man and woman who died in Donegal collision

More From The Irish Examiner